04/04/2026
📣 Peptide Update: What’s Happening with Peptides and the Category 2 List?
PART 1
You may have seen recent buzz around peptides like BPC‑157 and changes in its regulatory status — so here’s a straightforward breakdown of what it is, what’s changed, and how it might matter. 👇
🧬 What is BPC‑157?
BPC‑157 (short for Body Protection Compound‑157) is a synthetic peptide made up of 15 amino acids and originally studied for its role in supporting tissue repair and healing processes in animal research. It has been explored for effects like tendon and ligament healing, gut lining protection, reduced inflammation, and promoting blood‑vessel growth.
📣 What’s Happened Recently?
In March 2026, federal health officials announced that more than a dozen peptides previously on the Category 2 list — including BPC‑157 — are expected to be reclassified back to Category 1. This change would mean licensed compounding pharmacies could legally prepare them again under a prescription.
💡 Benefits:
Supports tissue repair by promoting recovery in tendons, ligaments, and muscles
Protects gut lining and helps maintain gastrointestinal health
Reduces inflammation in damaged or stressed tissues
Enhances healing through improved blood vessel growth and circulation
👉 Bottom line: The Category 1 reclassification improves regulated access and oversight. DM us or click below to book your wellness consultation and see how peptide therapy could support your recovery and overall health! 💪🩺
www.julaestheticsandmedical.com
